• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G 蛋白偶联雌激素受体 1 作为一种用于泛癌诊断、预后和免疫浸润的生物标志物的效用:一项综合的生物信息学分析。

Utility of G protein-coupled oestrogen receptor 1 as a biomarker for pan-cancer diagnosis, prognosis and immune infiltration: a comprehensive bioinformatics analysis.

机构信息

Department of Anesthesiology, Sichuan Cancer Center, Sichuan Cancer Hospital and Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China.

Department of Anesthesiology, Xichang People’s Hospital, Xichang, Sichuan, China.

出版信息

Aging (Albany NY). 2023 Nov 2;15(21):12021-12067. doi: 10.18632/aging.205162.

DOI:10.18632/aging.205162
PMID:37921845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10683611/
Abstract

BACKGROUND

The G protein-coupled oestrogen receptor () 1 mediates non-genomic oestrogen-related signalling and plays an important role in the regulation of cell growth and programmed cell death through multiple downstream pathways. Despite the increasing interest in the role of in cancer development, no pan-cancer analysis has been available for .

METHODS

In this study we performed a comprehensive analysis of the role of in pan-cancer via Human Protein Atlas (HPA), The Cancer Genome Atlas (TCGA), University of California, Santa Cruz Xena (UCSC XENA), Genotype-Tissue Expression (GTEx), MethSurv, The University of Alabama at Birmingham CANcer data analysis Portal (UALCAN), cBioPortal, STRING and TISIDB detabases, followed by enrichment analysis using R software.

RESULTS

was widely expressed in tissues and organs and differed in expression from normal tissue in a variety of cancers. In diagnostic assessment, it's Area Under the Curve (AUC) surpassed 0.9 in nine cancer types. Survival analysis showed that was correlated with the prognosis of 11 cancer types. Moreover, expression was associated with immune infiltration in multiple cancers.

CONCLUSIONS

In summary, has good diagnostic or prognostic value across various malignancies. Together with its extensive correlation with immune components, the aforementioned results suggests that shows promise in tumour diagnosis and prognosis, providing new ideas for precise and personalised anti-tumour strategies.

摘要

背景

G 蛋白偶联雌激素受体()1 介导非基因组雌激素相关信号转导,并通过多种下游途径在细胞生长和程序性细胞死亡的调节中发挥重要作用。尽管人们对在癌症发展中的作用越来越感兴趣,但尚未针对进行泛癌分析。

方法

本研究通过人类蛋白质图谱(HPA)、癌症基因组图谱(TCGA)、加利福尼亚大学圣克鲁斯 Xena(UCSC XENA)、基因型组织表达(GTEx)、MethSurv、阿拉巴马大学伯明翰癌症数据分析门户(UALCAN)、cBioPortal、STRING 和 TISIDB 数据库,对在泛癌中的作用进行了全面分析,随后使用 R 软件进行了富集分析。

结果

在组织和器官中广泛表达,在多种癌症中与正常组织的表达不同。在诊断评估中,它在九种癌症类型中的曲线下面积(AUC)超过 0.9。生存分析表明与 11 种癌症类型的预后相关。此外,在多种癌症中,表达与免疫浸润相关。

结论

总之,在各种恶性肿瘤中具有良好的诊断或预后价值。结合其与免疫成分的广泛相关性,上述结果表明在肿瘤诊断和预后方面具有潜力,为精准和个体化抗肿瘤策略提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/fde5f1c8d98a/aging-15-205162-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/de4dc8c53316/aging-15-205162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/2bafb2aa80df/aging-15-205162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/d4560bfc59cb/aging-15-205162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/d63b094b8fd1/aging-15-205162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/0cdbdd95b52e/aging-15-205162-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/625760d3f5a6/aging-15-205162-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/f36178a1e782/aging-15-205162-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/382f341d9ef0/aging-15-205162-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/74fa39efa4c9/aging-15-205162-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/ffcdde917bdf/aging-15-205162-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/fde5f1c8d98a/aging-15-205162-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/de4dc8c53316/aging-15-205162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/2bafb2aa80df/aging-15-205162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/d4560bfc59cb/aging-15-205162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/d63b094b8fd1/aging-15-205162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/0cdbdd95b52e/aging-15-205162-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/625760d3f5a6/aging-15-205162-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/f36178a1e782/aging-15-205162-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/382f341d9ef0/aging-15-205162-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/74fa39efa4c9/aging-15-205162-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/ffcdde917bdf/aging-15-205162-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ae/10683611/fde5f1c8d98a/aging-15-205162-g011.jpg

相似文献

1
Utility of G protein-coupled oestrogen receptor 1 as a biomarker for pan-cancer diagnosis, prognosis and immune infiltration: a comprehensive bioinformatics analysis.G 蛋白偶联雌激素受体 1 作为一种用于泛癌诊断、预后和免疫浸润的生物标志物的效用:一项综合的生物信息学分析。
Aging (Albany NY). 2023 Nov 2;15(21):12021-12067. doi: 10.18632/aging.205162.
2
Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.NR1H4 在肾透明细胞癌中的临床意义和致癌功能。
BMC Cancer. 2022 Sep 19;22(1):995. doi: 10.1186/s12885-022-10087-4.
3
Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.泛癌分析揭示 RAB3B 表达与多种癌症肿瘤异质性、免疫微环境和预后的相关性。
Sci Rep. 2024 Apr 30;14(1):9881. doi: 10.1038/s41598-024-60581-x.
4
Pan-cancer bioinformatics analysis of hepatic leukemia factor and further validation in colorectal cancer.肝白血病因子的泛癌生物信息学分析及在结直肠癌中的进一步验证
Transl Cancer Res. 2024 Jul 31;13(7):3299-3317. doi: 10.21037/tcr-23-2274. Epub 2024 Jul 26.
5
Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis.HELLS 在泛癌中的诊断、预后和免疫作用:生物信息学分析。
Front Immunol. 2022 Jun 14;13:870726. doi: 10.3389/fimmu.2022.870726. eCollection 2022.
6
The gene expression of GPER1 is low in fresh samples of papillary thyroid carcinoma (PTC), and in silico analysis.在新鲜的甲状腺乳头状癌(PTC)样本中,GPER1 的基因表达水平较低,通过计算机分析预测。
Mol Cell Endocrinol. 2021 Sep 15;535:111397. doi: 10.1016/j.mce.2021.111397. Epub 2021 Jul 14.
7
ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.ORC6,一种新的预后生物标志物,与前列腺腺癌中的 T 调节细胞浸润相关:泛癌分析。
BMC Cancer. 2023 Mar 29;23(1):285. doi: 10.1186/s12885-023-10763-z.
8
The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.GPER1/SPOP 轴介导 ERα 的泛素化依赖性降解,从而抑制雌激素诱导的乳腺癌生长。
Cancer Lett. 2021 Feb 1;498:54-69. doi: 10.1016/j.canlet.2020.10.019. Epub 2020 Oct 15.
9
Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.多组学分析 N6-甲基腺苷读码器 IGF2BP3 作为泛癌的有前途的生物标志物。
Front Immunol. 2023 Jan 25;14:1071675. doi: 10.3389/fimmu.2023.1071675. eCollection 2023.
10
NALCN is a potential biomarker and therapeutic target in human cancers.NALCN是人类癌症中的一种潜在生物标志物和治疗靶点。
Front Genet. 2023 Apr 19;14:1164707. doi: 10.3389/fgene.2023.1164707. eCollection 2023.

引用本文的文献

1
The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors.雌激素及雌激素受体在头颈部肿瘤中的作用
Cancers (Basel). 2024 Apr 19;16(8):1575. doi: 10.3390/cancers16081575.

本文引用的文献

1
Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells.敲低 G 蛋白偶联雌激素受体 1(GPER1)增强宫颈癌细胞的肿瘤支持性。
Cancer Genomics Proteomics. 2023 May-Jun;20(3):281-297. doi: 10.21873/cgp.20381.
2
Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis.细胞质 G 蛋白偶联雌激素受体 1 作为乳腺癌的预后指标:一项荟萃分析。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221131664. doi: 10.1177/15330338221131664.
3
Receiver operating characteristic curve: overview and practical use for clinicians.
受试者工作特征曲线:概述与临床医师的实际应用
Korean J Anesthesiol. 2022 Feb;75(1):25-36. doi: 10.4097/kja.21209. Epub 2022 Jan 18.
4
Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis.雌激素-孕激素轴在泛癌中的预后作用及靶向潜力
Front Oncol. 2021 Jul 12;11:636365. doi: 10.3389/fonc.2021.636365. eCollection 2021.
5
The ever-increasing importance of cancer as a leading cause of premature death worldwide.癌症作为全球范围内导致过早死亡的主要原因,其重要性日益增加。
Cancer. 2021 Aug 15;127(16):3029-3030. doi: 10.1002/cncr.33587. Epub 2021 Jun 4.
6
G Protein-Coupled Estrogen Receptor in Cancer and Stromal Cells: Functions and Novel Therapeutic Perspectives.G 蛋白偶联雌激素受体在癌症和基质细胞中的作用及新的治疗前景。
Cells. 2021 Mar 17;10(3):672. doi: 10.3390/cells10030672.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT-Mediated EMT.GPER1基因沉默通过抑制PI3K/AKT介导的上皮-间质转化来抑制胃癌细胞的增殖、迁移和侵袭。
Front Cell Dev Biol. 2020 Dec 21;8:591239. doi: 10.3389/fcell.2020.591239. eCollection 2020.
10
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.关于 G 蛋白偶联雌激素受体 GPER 功能调节的治疗观点。
Front Endocrinol (Lausanne). 2020 Nov 23;11:591217. doi: 10.3389/fendo.2020.591217. eCollection 2020.